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ABSTRAK
Vaksinasi influenza dan pneumokokal dewasa tidak digunakan sepenuhnya 
walaupun  jelas manfaatnya dari segi pengurangan kematian dan morbiditi di 
kalangan yang berisiko. Matlamat kajian ini adalah untuk meneliti pengetahuan 
doktor berkaitan dengan vaksinasi influenza dan pneumokokal, kepercayaan 
mereka dan halangan terhadap vaksinasi tersebut. Kajian keratan rentas ini 
dijalankan dengan menggunakan soal selidik bertulis di lapan klinik kesihatan 
di Bandar Kuching, Sarawak. Sejumlah 108 doktor telah menyertai kajian ini.  
Umur median peserta ialah 29 tahun (Nisbah antara kuartil 4.0). Median markah 
pengetahuan vakinasi influenza ialah 9 (Nisbah antara kuartil 3) manakala untuk 
pneumokokal adalah 8 (Nisbah antara kuartil 4). Peserta perempuan telah 
mendapat markah yang lebih tinggi untuk kedua-dua vaksin berbanding dengn 
peserta lelaki (P=0.005 & 0.007). Peratusan tertinggi untuk jawapan betul untuk 
vaksinasi influenza adalah untuk kesan sampingan (75.3%) manakala yang terendah 
adalah untuk kontraindikasi (9.3%). Peratusan tertinggi bagi jawapan betul bagi 
vaksinasi pneumokokal adalah untuk kesan sampingan (69.1%) manakala yang 
terendah adalah untuk indikasi kumpulan sasaran (6.2%). Kebanyakan peserta 
percaya bahawa vaksin pneumokokal dan influenza adalah selamat (92.8 & 99%) 
dan berfaedah (89.7 & 93.8%). Kos vaksin untuk influenza dan pneumokokal 
(94.8 & 96.9%) dan ketiadaan bekalan (86.6 & 89.7) adalah halangan utama untuk 
penggunaanya. Doktor penjagaan primer di sektor awam memiliki pengetahuan 
secara sederhana tentang kedua-dua vaksinasi untuk pesakit dewasa. Adalah 
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is compulsory for Malaysian Muslims 
travelling  to Saudi Arabia  to  perform  
Haj  pilgrimage  while  both   influenza 
and pneumococcal vaccinations are 
recommended especially in those 
with chronic debilitating diseases, 
immunosuppressed or elderly 
(Malaysian Society of Infectious 
dicadangkan supaya kekurangan pengetahuan yang telah dikenalpasti diatasi 
dengan penambahan ilmu dan halangan perlu diatasi supaya rawatan kesihatan 
yang lebih komprehensif dapat disampaikan kepada penduduk Malaysia yang 
semakin berumur.
Kata kunci: dewasa, kepercayaan, vaksin influenza, ilmu, vaksin pneumokokal 
ABSTRACT 
Adult influenza and pneumococcal vaccinations are grossly underutilized although 
there is clear benefit in reducing mortality and morbidity among those at risk.  
The aim of the study was to assess primary care physician’s knowledge on adult 
influenza and pneumococcal vaccinations, their beliefs and barriers to vaccination.  
A cross-sectional study using self-administered questionnaires was conducted 
at eight primary care centres in Kuching, Sarawak. A total of 108 primary care 
physicians participated in this study.  Median age of participants was 29 years (IQR 
4.0). The median knowledge score for influenza vaccine was 9 (IQR 3) and for 
pneumococcal vaccine was 8 (IQR 4). Female participants scored higher compared 
to their male counterparts for influenza and pneumococcal vaccines (P = 0.005 
& 0.007). The highest percentage of correct responses for influenza vaccination 
was for side effects (75.3%) while the lowest was for contraindications (9.3%).  
The highest percentage of correct responses for pneumococcal vaccination was 
for side effects (69.1%) while the lowest was for advocated target groups (6.2%).  
Most participants believed that pneumococcal and influenza vaccines were safe 
(92.8 & 99%) and beneficial for patients (89.7 & 93.8%). Cost of influenza and 
pneumococcal vaccines (94.8% & 96.9%) and their availability (86.6% & 89.7%) 
were the main barriers to prescribing them. Primary care physicians in the public 
sector have moderate knowledge of both adult vaccinations. Areas of knowledge 
paucity and barriers need to be addressed to ensure a more comprehensive health 
care delivery to the aging Malaysian population.  
Keywords: adult, belief, influenza vaccines, knowledge, pneumococcal vaccines 
INTRODUCTION 
Influenza and pneumococcal 
vaccinations in Malaysia are still not 
widely used although the Ministry of 
Health had advocated it in the national 
guidelines for Adult Immunization. 
Currently, meningococcal vaccination 
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Diseases and Chemotherapy 2014). 
In general, compared to pediatric 
vaccinations, there is poor uptake 
for both these adult vaccines (Isahak 
2000). Even in developed countries 
such as USA, adult influenza and 
pneumococcal vaccinations covers 
only about 71.5% and 61.3% of those 
aged 65 and above (Williams et al. 
2015). Influenza and pneumococcal 
infections in adults are responsible 
for a high morbidity and mortality in 
Asia. A study from Singapore identified 
influenza as the predominant cause for 
pneumonia with an all-cause excess 
mortality rate of 14.8/100,000 person-
years for all ages (Chow et al. 2006). In 
Malaysia, Streptococcal pneumoniae 
was the major cause of hospital 
admission particularly in the elderly 
and those with significant underlying 
comorbid diseases (Liam 2005). 
 The Malaysian population of those 
age 65 years and above is projected to 
increase to 2.2 million by the year 2020 
(Department of Statistics Malaysia 
2013). With the growing geriatric 
population, advancing health-care 
technology as well as a higher standard 
of living, the average life expectancy is 
expected to increase (Jaafar et al. 2013). 
The combination of these factors will 
further increase the disease burden 
from influenza and pneumococcus in 
the future. Therefore, physicians need 
to be aware of preventive aspects 
of these diseases. Currently, there is 
insufficient data regarding knowledge 
and barriers to influenza and 
pneumococcal vaccination among 
primary care doctors who are the 
main advocates for adult vaccination 
in the community. The aim of this 
study is to assess the knowledge, belief 
and barriers to adult influenza and 
pneumococcal vaccination among 
primary care physicians. 
MATERIALS AND METHODS 
This was a cross-sectional study 
conducted at 8 government primary 
care centres in Sarawak, East Malaysia. 
All doctors from these health clinics, 
including family medicine specialists, 
trainees and medical officers were 
invited to participate. General 
practitioners from private clinics, 
paramedics and support staff were 
excluded.  
 Knowledge regarding the vaccine 
was assessed using the adapted version 
of the original questionnaire (Romani 
et al. 2011). Additional questions for 
knowledge based on the Malaysian 
Adult Immunisation Guidelines 
(MOH & MSIDC 2003) and the latest 
CDC recommendations (Williams 
et. al 2015) were added. The final 
questionnaire for knowledge consists 
of 28 items which covered knowledge 
for both influenza and pneumococcal 
vaccinations. The score range for the 
influenza vaccination knowledge 
section was 0 to 14 points while that 
for pneumococcal vaccination was 
0-15 points. Higher points would 
reflect better knowledge.  
 Participant’s perceived barriers 
to prescribing these vaccines were 
assessed using the adapted version of 
the questionnaire authored by Romani 
et al (Romani et al. 2011). A single 
open-ended question was provided for 
participants to write barriers that were 
not stated in the options.
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 Participant’s belief regarding the 
vaccines, in particular vaccines’ 
safety and benefit, was assessed using 
adapted questionnaire developed from 
literature search and an expert panel 
review (Khoury and Salameh 2015). 
This section had 4 statements to which 
there were three answer options in a 
nominal Likert scale (Yes, No, Unsure). 
A pilot test was done among primary 
care doctors at an outpatient clinic 
of a similar setting. Test-retest 
for knowledge on influenza and 
pneumococcal vaccinations showed 
a Pearson reliability coefficient of 
0.81 for influenza vaccine knowledge 
and 0.84 for pneumococcal vaccine 
knowledge [Correlation for both were 
significant at 0.01 levels (2-tailed)]. 
 The questionnaires were distributed 
to participants during their weekly 
continuous medical education session. 
They were given protected time to 
answer the questionnaires which were 
collected upon completion. They then 
were given a brief introduction on the 
current guidelines recommendations 
for the two vaccines. Incomplete 
questionnaires were excluded from 
analysis. 
 Statistical analysis was done using 
the SPSS (Version 23) statistical 
package. Descriptive statistics were 
used for demography, beliefs and 
perceived barriers while the non-
parametric Mann-Whitney U test 
and Kruskal-Wallis tests were used 
to compare the knowledge with the 
doctor’s characteristics. This study 
received ethical approval from the 
Medical Research Ethics Committee 
of the National University of Malaysia 
and permission from the Sarawak State 
Health Department. 
RESULTS
A total of 119 doctors were approached 
and 108 consented to participate, 
out of which 97 questionnaires 
were complete and were subjected 
for analysis. The median age of 
participants was 29 years (IQR 4.0) 
with the youngest being 26 and the 
oldest, 54 years of age. Majority of 
the participants were females (70%) 
and about half of them belong to the 
Malay ethnic group (49.4%). Most of 
them had 10 years or less working 
experience (90.7%) and had a basic 
degree in medicine (94.8%) (Table 1). 
 Participants mostly received 
information regarding adult influenza 
and pneumococcal vaccinations 
from the internet (66%, 64.9%), from 
colleagues (49.5%, 51.5%) and from 
meetings or conferences (49.5%, 
45.4%), respectively (Table 2).
 The median knowledge score 
on adult influenza vaccine was 9 
(IQR 3) while that for pneumococcal 
vaccine was 8 (IQR 4). The highest 
percentage of correct responses for 
influenza vaccination was for side 
effects (75.3%) while the lowest was 
for contraindications (9.3%). As for 
pneumococcal vaccination, the highest 
percentage of correct responses also 
was for side effects (69.1%) and the 
lowest was for advocated target groups 
(6.2%) (Table 3).  
 Overall, female participants had 
significantly higher scores compared 
to their male counterparts for the 
knowledge on adult influenza and 
pneumococcal vaccines (P=0.005 and 
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0.007, respectively). Participants with a 
master’s degree in family medicine or 
its equivalent (P=0.023) scored higher 
on knowledge of pneumococcal 
vaccine compared to with those with a 
degree qualification. However, there is 
no significant association between the 
knowledge on both vaccinations’ with 
their age or years of practice (Table 4). 
Majority of the participants believed 
that pneumococcal and influenza 
vaccines were safe (92.8 and 99%) and 
beneficial (89.7 and 93.8%) (Table 5). 
 Common barriers towards 
Table 1:  Demographic characteristics of participants (n = 97)
Characteristics n (%)
Median Age (IQR) 29 (4.0)
Age Groups
25 to 34 years 86 (88.7)
35 to 44 years 10 (10.3)
45 to 54 years 1 (1.0)
Gender
Male 29 (30.0)
Female 68 (70.0)
Ethnicity
Malay 48 (49.4)
Chinese 25 (25.7)
Local Bumiputera 11 (11.4)
Indian 11 (11.4)
Others 2 (2.1)
Years of Practice
10 years 88 (90.7)
>10 years 9 (9.3)
Highest Qualification
MBBS/M.D. 92 (94.8)
Masters of Family Medicine or Equivalent 5 (5.2%)
MBBS = Bachelor of Medicine/Bachelor of Surgery, MD = Doctor of Medicine
Table 2:  Sources of information on adult influenza and pneumococcal vaccination 
Source Influenza Vaccine n (%) Pneumococcal Vaccine n (%)
Medical Journals/Websites 64 (66.0) 63 (64.9)
Colleagues 48 (49.5) 50 (51.5)
Meetings/Conferences 48 (49.5) 44 (45.4)
Clinical Practice Guidelines 46 (47.4) 41 (42.3)
Pharmaceutical Representatives 33 (34.0) 31 (32.0)
Others 3 (3.1) 7 (7.2)
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prescribing both influenza and 
pneumococcal vaccines include 
cost (94.8% and 96.9%), vaccines’ 
availability (86.6% and 89.7%) and 
Table 3:  Percentage of correct responses for influenza and pneumococcal vaccination 
in different domains 
Domains Influenza Vaccination n (%) Pneumococcal Vaccination n (%)
Age Indication 50 (51.5) 64 (66.0)
Advocated target groups 32 (33.0) 6 (6.2)
Contraindications 9 (9.3) 12 (12.4)
Frequency of vaccination 52 (53.6) 14 (14.4)
Mode of administration 66 (68.0) 8 (8.2)
Side effects 73 (75.3) 67 (69.1)
Vaccine type (Live/Attenuated) 47 (48.5) 48 (49.5)
Table 4:  Association between knowledge scores and demographic characteristics 
Participant’s 
Demography 
Influenza Median 
(IQR) Test P value
Pneumococcal 
Median (IQR) Test P value
Overall 9 (3.00) - 8 (4.00) -
Gender
   Male 8 (3.00) Mann-Whitney U 
P = 0.005
6 (3, 50) Mann-Whitney U
P = 0.007   Female 10 (2.75) 9 (3.75)
Age
   25 to 34 years 9 (3.00) x2 
P = 0.526
8 (3.00) x2 
P = 0.071   35 to 44 years 10 (5.00) 10 (5.00)
   45 to 54 years 10 (0.00) 11 (0.00)
Qualification
   Degree 9 (3.00) Mann-Whitney U 
P = 0.299
8 (4.00) Mann-Whitney U 
P = 0.023   Masters 10 (3.00) 10 (2.00)
Experience
   ≤10 years 9 (3.00) Mann-Whitney U 
P = 0.369
8 (4.00) Mann-Whitney U 
P = 0.112   >10 years 10 (6.00) 10 (6.00)
Table 5:  Participants’ belief regarding adult influenza and pneumococcal vaccination
Yes n (%) No n (%) Unsure n (%)
Influenza Vaccination
Perceived safe 96 (99.0%) 0 (0%) 1 (1%)
Perceived  beneficial 91 (93.8%) 3 (3.1%) 3 (3.1%)
Pneumococcal Vaccination
Perceived  safe 90 (92.8%) 2 (2.1%) 5 (5.1%)
Perceived  beneficial 87 (89.7%) 4 (4.1%) 6 (6.2%)
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lack of knowledge regarding patient’s 
immunization status (72.2% for both). 
More than half (61.9% and 56.7%) 
of the participants were not sure 
of the guidelines for influenza and 
pneumococcal vaccinations (Table 6). 
A single respondent identified that the 
lack of awareness and promotion for 
the use of these vaccines was another 
barrier towards prescribing these two 
vaccines. 
DISCUSSION
Influenza and pneumococcal 
infections have significant impact on 
disease burden among adults and 
elderly population worldwide. A meta-
analysis study has shown that seasonal 
influenza vaccine was significantly 
effective against influenza during 
epidemic seasons in elderly people 
(Darvishian et al. 2014). Similarly, 
pneumococcal vaccine is effective 
against invasive pneumococcal 
disease among immunocompetent 
adults and preventing all–cause 
pneumonia in low-income countries 
hence its current recommendations in 
many countries (Moberley et al. 2013). 
A case-control study in Spain among 
the elderly who were vaccinated in the 
five previous years with the 23-valent 
polysaccharide pneumococcal 
vaccine also demonstrated a reduced 
risk for all cause community-
acquired pneumonia hospitalization 
(Domínguez et al. 2017).
 The current study suggests that the 
main source of information regarding 
vaccination obtained by participants 
is through the internet which depicts 
that most doctors are internet savvy 
and had fast access to the internet 
Table 6:  Barriers to prescribing influenza and pneumococcal vaccines
Barriers Influenza n (%) Pneumococcal n (%)
1. Cost Yes 92 (94.8) 94 (96.9)
No 5 (5.2) 3 (3.1)
2. Availability Yes 84 (86.6) 87 (89.7)
No 13 (13.4) 10 (10.3)
3. Not knowing  immunization  status Yes 70 (72.2) 70 (72.2)
No 27 (27.8) 27 (27.8)
4. Not sure of  guidelines Yes 60 (61.9) 55 (56.7)
No 37 (38.1) 41 (43.3)
5. Patient refusal Yes 57 (58.8) 57 (58.8)
No 40 (41.2) 40 (41.2)
6. Shortage of time & not  attending  wellness visits Yes 56 (57.7) 60 (61.9)
No 41 (42.3) 37 (38.1)
7. Concern  about  efficacy Yes 34 (35.1) 35 (36.1)
No 63 (64.9) 62 (63.9)
8. Concern about safety Yes 32 (33.0) 35 (36.1)
No 65 (67.0) 62 (63.9)
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through smart phones and computers. 
Most participants in this study had a 
moderate level of knowledge regarding 
both influenza and pneumococcal 
vaccines. This is comparable with the 
knowledge accuracy of between 53 to 
58% for the same two vaccines among 
Lebanese family physicians (Romani et 
al. 2011).
 High scores for knowledge 
regarding both vaccines’ side effects 
show that participants are aware of 
their side effect profiles. However, 
knowledge regarding contraindications 
and the advocated target groups for 
vaccination were poor which may 
act as a potential barrier towards 
prescribing these vaccines. A large 
proportion (93.8%) of participants 
were not aware of the correct target 
groups indicated for pneumococcal 
vaccination and for about two-thirds 
(67%) for influenza vaccine target 
groups. Regarding vaccine type, 
only half of the participants (48.5%, 
49.5%) knew that both influenza 
and pneumococcal vaccines were 
not live vaccines (Table 3). This is 
a cause for concern as knowledge 
on the vaccine type is important for 
making a decision on whether or 
not to advocate them particularly for 
immunosuppressed populations. This 
group may get excluded from vaccine 
recommendation if it were thought to 
be live vaccines.  This study also found 
that almost one third of the participants 
had concerns on the safety of influenza 
and pneumococcal vaccinations which 
could reflect inadequate vaccine 
knowledge (Table 6). This is a large 
number when compared to Western 
data (11.5% and 6.8%, respectively) 
(Klett-Tammen et al. 2016).
 As for pneumococcal vaccine 
knowledge domains, only 8.2% 
knew the correct mode of vaccine 
administration which can be either 
via intramuscular or subcutaneous 
routes. Knowledge on the frequency of 
vaccination of the same vaccine was 
also poor with only 14.4% correctly 
answering that it should be given once 
after 65 years of age or once every 
five years if given prior to 65 years of 
age. These shortcomings need to be 
addressed as vaccination schedules 
get updated from time to time due 
to emerging new evidences. It is 
important that primary care doctors 
keep themselves abreast with the 
latest vaccine recommendations by 
sharing information through regular 
Continuous Medical Education (CME). 
All in all, they who are equipped with 
accurate knowledge on influenza 
and pneumococcal vaccines would 
competently utilize both vaccines in 
preventive health services for the adult 
community.   
 Female doctors seem to have 
fairly better knowledge regarding 
adult influenza and pneumococcal 
vaccinations compared to their male 
counterparts. This could be due to their 
diligent nature to keep up with medical 
developments (Ismail 2014). However 
this finding may not be generalized 
as another study found no significant 
differences in knowledge between 
genders (Khazaeipour et al. 2010). 
Those with a master’s degree in family 
medicine or its equivalent had higher 
scores as they have more training, 
experience and exposure; hence 
their higher likelihood to have better 
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levels of knowledge on both vaccines.  
Although doctor’s age and experience 
were not significant variables for 
determining vaccination knowledge 
in this study, an Italian study showed 
otherwise. Using multiple logistic 
regression analysis, they showed older 
general practitioners and those with 
fewer years of professional activity 
significantly had greater knowledge 
that influenza and pneumococcal 
vaccinations were recommended to 
the elderly (Pavia et. al 2003).       
 A large majority of participants are 
confident regarding the safety profile 
and benefits of both influenza and 
pneumococcal vaccines. This is an 
important finding as these positive 
beliefs would encourage them to 
advise both vaccines’ uptake to patients 
especially those in the vulnerable 
group (Nichol & Zimmerman 2001), 
(MacDougall et al. 2015).  
 Participants in this study identified 
that cost and the non-availability are 
the main barriers towards prescribing 
these vaccines. In Malaysia, only 
the basic and essential childhood 
vaccines are provided at no cost by the 
government primary care clinics. Adult 
influenza and pneumococcal vaccines 
are not provided or subsidized by the 
government at the primary health care 
level. There is however a small quota 
for free influenza and pneumococcal 
vaccines only at tertiary government 
hospitals, reserved for patients at 
high risk. The current market price 
for a dose of influenza vaccine ranges 
between RM100 to RM150 per dose 
while a dose for pneumococcal 
vaccine is even costlier which can 
range between RM200 to RM250. 
Although this may seem burdensome 
to self-paying patients especially for 
the latter vaccine, vaccinating those at 
high risk of pneumococcal infections 
had in fact been shown to be more 
cost-effective in preventing hospital 
admissions and morbidity (Ament et al. 
2000). Therefore, vaccination advice 
should be encouraged at primary care 
level given its benefits in the long term 
management of patients who are at 
risk. 
 The participants also identified that 
not knowing their patient’s current 
vaccination status was itself a barrier 
towards prescribing influenza and 
pneumococcal vaccines. One solution 
to overcome this barrier is to attach 
a summary sheet of each patient’s 
health status onto the first page of their 
health record. This can be periodically 
updated by medical staff and easily 
accessed by doctors. Automated 
electronic patient reminders and 
standing orders are other options 
and may be beneficial in clinics with 
teleprimary care (TPC) facilities (Nichol 
& Zimmerman 2001).   
 Since more than half of the 
participants did not know the guidelines 
for influenza and pneumococcal 
vaccinations, it is suggested that the 
latest Malaysian Adult Immunization 
Guidelines be revisited from time to time 
at all primary care clinics during their 
regular CME sessions with periodical 
updates regarding availability, 
indications and benefits of both adult 
vaccinations along with other relevant 
adult vaccines. Family physicians and 
tertiary centre physicians need to join 
forces to facilitate adult vaccination. 
Co-ordinating care and sharing 
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regular updates on adult vaccinations 
could help reduce the morbidity and 
mortality from these diseases and 
eventually reduce the overall burden 
on health cost. 
 Limitations in this study include 
those due to cross sectional nature 
of the data.  This study was done at 
primary care centers in Sarawak hence 
these findings are not generalisable to 
the entire Malaysia.  
CONCLUSION
The findings from this study suggest 
that primary care physicians have a 
moderate level of knowledge regarding 
influenza and pneumococcal 
vaccinations. However, there are areas 
of knowledge such as contraindications, 
vaccine type and the advocated target 
groups requiring vaccination, which 
are lacking and need to be addressed. 
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